Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients

Sofie Lock Johansson; Helle Wulf-Johansson; Anders Schlosser; Ingrid L Titlestad; Bruce Miller; Ruth Tal-Singer; Uffe Holmskov; Jørgen Vestbo; Grith Lykke Sørensen

doi:10.1183/23120541.00021-2019

Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients

Sofie Lock Johansson, Helle Wulf-Johansson, Anders Schlosser, Ingrid L Titlestad, Bruce Miller, Ruth Tal-Singer, Uffe Holmskov, Jørgen Vestbo, Grith Lykke Sørensen^*

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

Abstract

Circulating MFAP4 is a relevant biomarker to identify COPD patients at risk of death and cardiovascular comorbidity after smoking cessation http://ow.ly/6vnL30o8t1g.

Originalsprog	Engelsk
Tidsskrift	ERJ Open Research
Vol/bind	5
Udgave nummer	2
DOI	https://doi.org/10.1183/23120541.00021-2019
Status	Udgivet - apr. 2019
Udgivet eksternt	Ja

Adgang til dokumentet

10.1183/23120541.00021-2019

Citationsformater

Johansson, S. L., Wulf-Johansson, H., Schlosser, A., Titlestad, I. L., Miller, B., Tal-Singer, R., Holmskov, U., Vestbo, J., & Sørensen, G. L. (2019). Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients. ERJ Open Research, 5(2). https://doi.org/10.1183/23120541.00021-2019

@article{7f1445bf6d7e4b78a7a8183902a704d3,

title = "Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients",

abstract = "Circulating MFAP4 is a relevant biomarker to identify COPD patients at risk of death and cardiovascular comorbidity after smoking cessation http://ow.ly/6vnL30o8t1g.",

author = "Johansson, {Sofie Lock} and Helle Wulf-Johansson and Anders Schlosser and Titlestad, {Ingrid L} and Bruce Miller and Ruth Tal-Singer and Uffe Holmskov and J{\o}rgen Vestbo and S{\o}rensen, {Grith Lykke}",

year = "2019",

month = apr,

doi = "10.1183/23120541.00021-2019",

language = "English",

volume = "5",

journal = "ERJ Open Research",

issn = "2312-0541",

publisher = "European Respiratory Society",

number = "2",

}

Johansson, SL, Wulf-Johansson, H, Schlosser, A, Titlestad, IL, Miller, B, Tal-Singer, R, Holmskov, U, Vestbo, J & Sørensen, GL 2019, 'Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients', ERJ Open Research, bind 5, nr. 2. https://doi.org/10.1183/23120541.00021-2019

TY - JOUR

T1 - Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients

AU - Johansson, Sofie Lock

AU - Wulf-Johansson, Helle

AU - Schlosser, Anders

AU - Titlestad, Ingrid L

AU - Miller, Bruce

AU - Tal-Singer, Ruth

AU - Holmskov, Uffe

AU - Vestbo, Jørgen

AU - Sørensen, Grith Lykke

PY - 2019/4

Y1 - 2019/4

N2 - Circulating MFAP4 is a relevant biomarker to identify COPD patients at risk of death and cardiovascular comorbidity after smoking cessation http://ow.ly/6vnL30o8t1g.

AB - Circulating MFAP4 is a relevant biomarker to identify COPD patients at risk of death and cardiovascular comorbidity after smoking cessation http://ow.ly/6vnL30o8t1g.

U2 - 10.1183/23120541.00021-2019

DO - 10.1183/23120541.00021-2019

M3 - Letter

C2 - 31024964

SN - 2312-0541

VL - 5

JO - ERJ Open Research

JF - ERJ Open Research

IS - 2

ER -

Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater